Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer...

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Cancer stem cells (CSCs) drive tumor progression and metastasis.
• CD8+ T cells play a critical role in anti-tumor immunity.
• The interaction between CSCs and immune cells is complex and influences tumor fate.

Purpose of the Study:

• To investigate the role of T-cell receptor (TCR) CD8+ T cells in modulating cancer stem cell (CSC) properties.
• To elucidate the molecular mechanisms underlying CSC-T cell cross-talk.
• To identify potential therapeutic targets for inhibiting CSC-mediated tumor progression.

Main Methods:

• Co-culture systems of CSCs and TCR CD8+ T cells.
• VEGFR2 signaling pathway analysis.
• Assessment of CSC markers and tumor-initiating capacity.
• In vivo tumor growth and metastasis models.

Main Results:

• Cross-talk between TCR CD8+ T cells and CSCs induces aggressive CSC phenotypes.
• VEGFR2 signaling axis is crucial for mediating this cross-talk.
• VEGFR2 activation in CSCs enhances their stemness and promotes tumor progression.

Conclusions:

• TCR CD8+ T cells can paradoxically promote tumor progression by enhancing CSC aggressiveness via VEGFR2 signaling.
• Targeting the VEGFR2 axis may represent a novel strategy to overcome CSC-mediated tumor resistance and metastasis.